We are continuously evaluating new opportunities to further expand our pipeline of novel, disruptive programs. We focus on drug candidates that:

• Are new molecular entities modulating novel targets, meaning they have a real opportunity to be potential first-in-class and/or best-in-class treatments
• Satisfy an unmet medical need or provide a newer, improved alternative to existing therapies
• Have demonstrated positive results in animal disease models and/or clinical studies
• Are capable of being, or have been, patent protected
• Possess significant sales potential in major global markets

We also understand that it takes a passionate, dedicated team to truly make a difference in patients’ lives. As such, we’re always looking for creative ways to forge long-standing partnerships that will help us efficiently and effectively advance our existing programs on a global scale.

If you have a fresh technology that you believe may be of interest to us, or if you’re interested to collaborate on any of our current development-stage programs, please contact us at bd@frtx.com or fill out the form below.